Functional neuroimaging findings in healthy middle-aged adults at risk of Alzheimer’s disease.
Habib M, Mak E, Gabel S, Su L, Williams G, Waldman A, Wells K, Ritchie K, Ritchie C, O’Brien JT. […]
Search Results for:
Detecting cognitive changes in preclinical Alzheimer’s disease: a review of its feasibility.
Mortamais M, Ash JA, Harrison J, Kaye J, Kramer J, Randolph C, Pose C, Albala B, Ropacki M, Ritchie CW, […]
Structural neuroimaging in preclinical dementia: from microstructural deficits and grey matter atrophy to macroscale connectomic changes.
Mak E, Gabel S, Mirette H, Su L, Williams GB, Waldman A, Wells K, Ritchie K, Ritchie C, O’Brien J. […]
The clinical picture of Alzheimer’s disease in the decade before diagnosis: clinical and biomarker trajectories.
Ritchie K, Carrière I, Berr C, Amieva H, Dartigues JF, Ancelin ML, Ritchie CW. The Journal of clinical psychiatry. 2016 […]
Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors.
Ritchie K, Carrière I, Ritchie CW, Berr C, Artero S, Ancelin ML. BMJ. 2010 PMC2917002 […]
Perspectives on Communicating Biomarker-Based Assessments of Alzheimer’s Disease to Cognitively Healthy Individuals.
Milne R, Bunnik E, Diaz A, Richard E, Badger S, Gove D, Georges J, Fauria K, Molinuevo JL, Wells K, […]
